NUTRA PHARMA CORP. (NPHC)

0.00 +0.00% (+0.00)

Over 5Y: -97.4%

2026-08-28
0 0
2021 2022 2023 2024 2025 2026

Financials Quarterly

Q3 '21 — Revenue: 19.3K Q3 '21 — Operating Cash Flow: -412.9K Q3 '21 — Free Cash Flow: -417.5K Q3 '21 — Net Income: 15.4M Q4 '21 — Revenue: 26K Q4 '21 — Operating Cash Flow: -233.7K Q4 '21 — Free Cash Flow: -238K Q4 '21 — Net Income: 2.1M Q1 '22 — Revenue: 13.8K Q1 '22 — Operating Cash Flow: -258.2K Q1 '22 — Free Cash Flow: -316.2K Q1 '22 — Net Income: 5M Q2 '22 — Revenue: 28.4K Q2 '22 — Operating Cash Flow: -284.8K Q2 '22 — Free Cash Flow: -284.8K Q2 '22 — Net Income: -645.8K Q3 '22 — Revenue: 24.6K Q3 '22 — Operating Cash Flow: -165.3K Q3 '22 — Free Cash Flow: -165.3K Q3 '22 — Net Income: 577.2K Q4 '22 — Revenue: 79K Q4 '22 — Operating Cash Flow: -54K Q4 '22 — Free Cash Flow: -54K Q4 '22 — Net Income: 3.2M Q1 '23 — Revenue: 54.5K Q1 '23 — Operating Cash Flow: -92.8K Q1 '23 — Net Income: -592.6K Q2 '23 — Revenue: 52.4K Q2 '23 — Operating Cash Flow: -186.8K Q2 '23 — Net Income: -279.2K Q3 '23 — Revenue: 51.6K Q3 '23 — Operating Cash Flow: -84.2K Q3 '23 — Net Income: -278.5K Q4 '23 — Revenue: 47K Q4 '23 — Operating Cash Flow: -186.2K Q4 '23 — Net Income: -243.1K Q1 '24 — Revenue: 37.7K Q1 '24 — Operating Cash Flow: -171.2K Q1 '24 — Net Income: -426.9K Q2 '24 — Revenue: 51.7K Q2 '24 — Operating Cash Flow: -93.6K Q2 '24 — Net Income: -367.1K Q3 '24 — Revenue: 75K Q3 '24 — Operating Cash Flow: 19.1K Q3 '24 — Net Income: -260.7K Q4 '24 — Revenue: 81.9K Q4 '24 — Operating Cash Flow: -178.2K Q4 '24 — Net Income: -230.9K Q1 '25 — Revenue: 74K Q1 '25 — Operating Cash Flow: -405K Q1 '25 — Free Cash Flow: -431.1K Q1 '25 — Net Income: -1.4M Q2 '25 — Revenue: 84.5K Q2 '25 — Operating Cash Flow: -288.4K Q2 '25 — Free Cash Flow: -288.4K Q2 '25 — Net Income: 369.6K Q3 '25 — Revenue: 70.2K Q3 '25 — Operating Cash Flow: -250.8K Q3 '25 — Free Cash Flow: -250.8K Q3 '25 — Net Income: -523.5K Q4 '25 — Revenue: 28.9K Q4 '25 — Operating Cash Flow: -219.8K Q4 '25 — Free Cash Flow: -219.8K Q4 '25 — Net Income: -488.5K Q1 '26 — Revenue: 27.2K Q1 '26 — Operating Cash Flow: -327.8K Q1 '26 — Net Income: -459.7K Q2 '26 — Revenue: 34.5K Q2 '26 — Operating Cash Flow: -251.2K Q2 '26 — Net Income: -3.9M 0 4M 8M 12M 16M
Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26
Revenue Operating Cash Flow Free Cash Flow Net Income

Figures as at 2026-06-30, reported in USD. The newest fact in the filings is dated 2026-06-30, 61 days ago. Nothing on this page is advice.

How it scores

Five questions, each answered by the measures under it. Every figure is the company's own; the bar beside it is where that figure sits among the companies read here — the top fifth, the bottom fifth, or somewhere between. Not among all listed companies, and for a valuation multiple the low end is the good end.

Quality

How much of the revenue is really kept — and what did it take to earn it?

0.6
SBC / sales 24.8%
OE margin -693.6%
Oper. margin -1017.8%
ROIC -34.3%
Accruals -701.7%
Gross margin 78.1%
EBITDA margin -1011.4%
FCF margin -668.9%
OCF margin -652.7%
ROA -870.3%
OCF / EBIT —
Profit margin —
ROCE —
ROE —

5 of 17 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Valuation

What does the price ask for what the company earns, owns and pays out?

0.5
Div. yield —
EV/EBIT —
EV/GP —
EV/OE —
EV/Sales —
FCF yield —
Fwd P/E —
P/B —
P/C —
P/E —
PEG —

0 of 12 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Durability

How predictable is the revenue, and how much of it is already committed?

3.6
RPO / sales —
RPO growth —
Segment HHI —

3 of 7 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Resilience

Can the balance sheet absorb a bad year?

1.2
ND/EBITDA —
Current ratio 0.021×
Interest cover -68.2×
Cash / Debt 0.0012×
F-score 4.0 pts
Quick ratio 0.02×
Cash runway —
Debt / Eq —
Debt payback —
Equity / Assets —
Net debt / Eq —
Payout —

3 of 12 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Growth

Is the business getting bigger, and is it getting more profitable?

4.2
Sales CAGR 4Y +27.4%
Sales/sh Y/Y -49.7%
Sales Q/Q -59.2%
Div. growth —
EBIT CAGR —
EBIT Y/Y —
EPS CAGR 4Y —
EPS Y/Y —
EPS next Y —

4 of 13 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

A measure absent from a block could not be computed from this company's filings. It is left out rather than scored as though it were bad, and the dimension is averaged over what remains. A score is measured against a fixed scale this model states; the bar is measured against the other companies, so the two can disagree — and where they do, that disagreement is the more interesting figure.